Herein, we found that EVs derived from normal HLSCs have the potential to correct ASS1 enzyme deficiency in hepatocytes differentiated from HLSCs derived from a patient with citrullinemia type I, suggesting a potential application of EVs derived from stem cells in some inherited diseases. The gene discussed is ASS1; the disease is citrullinemia type I.